Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory‐Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
Mona Askar(Robert Koch Institute), Thomas Harder(Robert Koch Institute), Timo Brugger(University of Freiburg), Ole Wichmann(Robert Koch Institute), Christine Schmucker(University of Freiburg), Waldemar Siemens(University Medical Center Freiburg), Jan M Stratil(UMIT - Private Universität für Gesundheitswissenschaften, Medizinische Informatik und Technik), Angeliki Melidou(Animal and Plant Health Agency), Johanna Schlaberg(Robert Koch Institute), Kate Olsson(European Centre for Disease Prevention and Control), Johanna Rubin(Public Health Agency of Sweden), Wiebe Külper‐Schiek(Robert Koch Institute), Ioanna D. Pavlopoulou(National and Kapodistrian University of Athens), Veronika Učakar(National Institute of Public Health), Vanessa Piechotta(Robert Koch Institute), Hanna Nohynek(Finnish Institute for Health and Welfare), Joerg J Meerpohl(University Medical Center Freiburg), Tyra Grove Krause(Statens Serum Institut), Karam Adel Ali(European Centre for Disease Prevention and Control), Annika Falman(Robert Koch Institute), Jørgen de Jonge(National Institute for Public Health and the Environment), Kari Johansen(European Centre for Disease Prevention and Control), Jaime Jesús Pérez(Instituto Murciano de Investigación Biosanitaria), Carmen Olmedo, Madeleine Batke(Robert Koch Institute), Anna Hayman Robertson(Norwegian Institute of Public Health)
Cited by 12
Related Papers
GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
|Journal of Clinical Epidemiology|2013|1.3k
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles—continuous outcomes
|Journal of Clinical Epidemiology|2012|761
Living systematic review: 1. Introduction—the why, what, when, and how
|Journal of Clinical Epidemiology|2017|676